It is discovered that human protein X will cure patients infected with Ebola describe how to produce large amounts of protein X, that can be used for treatment of humans

1. Identify the gene sequence for protein X: The first step in producing large amounts of protein X is to identify the gene sequence that codes for it. This can be done by analyzing the genome of humans who possess the protein X.

2. Clone the gene: Once the gene sequence for protein X has been identified, it can be cloned using molecular biology techniques. This involves isolating the gene sequence and inserting it into a plasmid vector, which can then be introduced into a host organism for expression.

3. Express the gene in a host organism: The cloned gene for protein X can be expressed in a host organism such as bacteria, yeast, or mammalian cells. Each of these organisms has its own advantages and disadvantages for protein production, so the choice of host organism will depend on factors such as protein folding and post-translational modifications.

4. Purify the protein X: Once the protein X has been expressed in the host organism, it can be purified using techniques such as affinity chromatography, ion exchange chromatography, and size exclusion chromatography. Purification is essential to ensure that the protein X is free of contaminants and is in its native form.

5. Scale up production: Once the purification process has been optimized, the production of protein X can be scaled up to generate large quantities of the protein. This can be achieved by using larger cultures of the host organism and optimizing the growth conditions to maximize protein yield.

6. Quality control: Before the protein X can be used for treatment of patients infected with Ebola, it must undergo rigorous quality control testing to ensure its safety and efficacy. This can include testing for purity, potency, and stability of the protein X.

7. Formulation and delivery: Finally, the purified protein X can be formulated into a suitable dosage form for administration to patients. This can include formulation into a liquid solution for injection or a solid dosage form for oral administration.

By following these steps, large amounts of protein X can be produced for the treatment of patients infected with Ebola, potentially saving lives and controlling the spread of the disease.